Accession Number: | 0000891839-21-000316 |
Date: | 2021-09-30 |
Issuer: | VACCINEX, INC. (VCNX) |
Original Submission Date: |
FRIEBERG JACOB B.
C/O VACCINEX, INC.
1895 MOUNT HOPE AVENUE
ROCHESTER, NY 14620
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-30 | 0 | $0.00 | 63,519 | direct | ||||
COMMON STOCK | 2021-09-30 | 0 | $0.00 | 4,420 | indirect | f1 | |||
COMMON STOCK | 2021-09-30 | 0 | $0.00 | 4,121 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.16 | 2021-09-30 | deemed execution date | A | 6,233 (a) | 2021-09-30 | common stock 6,233 | $2.16 | 6,233 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 13.6 | deemed execution date | 0 ( ) | 2027-09-15 | common stock 6,396 | $13.60 | 6,396 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 5.26 | deemed execution date | 0 ( ) | 2029-03-30 | common stock 2,501 | $5.26 | 2,501 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 7.78 | deemed execution date | 0 ( ) | common stock 7,718 | $7.78 | 7,718 | direct | |||||
STOCK OPTION (RIGHT TO BUY) | 5.52 | deemed execution date | 0 ( ) | 2029-06-29 | common stock 2,385 | $5.52 | 2,385 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 7.17 | deemed execution date | 0 ( ) | 2029-09-27 | common stock 1,856 | $7.17 | 1,856 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 4.85 | deemed execution date | 0 ( ) | 2029-12-28 | common stock 2,737 | $4.85 | 2,737 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 4.0 | deemed execution date | 0 ( ) | 2030-03-29 | common stock 3,336 | $4.00 | 3,336 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 3.95 | deemed execution date | 0 ( ) | common stock 15,679 | $3.95 | 15,679 | direct | |||||
STOCK OPTION (RIGHT TO BUY) | 3.61 | deemed execution date | 0 ( ) | 2030-06-28 | common stock 3,756 | $3.61 | 3,756 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 1.78 | deemed execution date | 0 ( ) | 2030-09-28 | common stock 7,626 | $1.78 | 7,626 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 2.07 | deemed execution date | 0 ( ) | 2030-12-29 | common stock 6,545 | $2.07 | 6,545 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 2.98 | deemed execution date | 0 ( ) | 2031-03-31 | common stock 4,535 | $2.98 | 4,535 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 2.15 | deemed execution date | 0 ( ) | 2022-05-11 | common stock 28,586 | $2.15 | 28,586 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 2.8 | deemed execution date | 0 ( ) | 2021-06-30 | common stock 4,804 | $2.80 | 4,804 | direct |
ID | footnote |
---|---|
f1 | mr. frieberg's spouse is the owner of benbow estates, ltd. and mr. frieberg is an officer of benbow estates, ltd. mr. frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
f2 | mr. frieberg is the sole owner and president of gee eff services limited. |
f3 | exercisable in full as of the date of this report. |
f4 | this option expires on may 14, 2029 or five years following retirement or cessation of services, whichever occurs first. |
f5 | this option expires on may 12, 2030 or five years following retirement or cessation of services, whichever occurs first. |
f6 | this option expires on may 9, 2031 or five years following retirement or cessation of services, whichever occurs first. |
f7 | this option was granted pursuant to the company's 2018 omnibus incentive plan in a transaction exempt under rule 16b-3 and, except as otherwise provided in the award notice, expires on june 28, 2031. |
f8 | this option was granted pursuant to the company's 2018 omnibus incentive plan in a transaction exempt under rule 16b-3 and, except as otherwise provided in the award notice, expires on september 28, 2031. |